Journal · Updated 2026-08-11
Yucca Health Review 2026: The $146 'For Life' Promo, Decoded
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
Short answer — August 2026
Yucca Health's site-wide banner — "Exclusive Lifetime Offer Code: YUCCA4LIFE, $146/mo For Life" — decodes, per July 2026 captures, to: a new-patient, "as low as" entry rate on a six-month semaglutide plan, with tirzepatide's parallel figure at two hundred fifty-eight dollars on the same six-month structure, full pricing revealed only after intake ("shared after intake once eligibility is confirmed," per Yucca's own FAQ), an all-fifty-state provider claim, and no pharmacy named anywhere public. On our records that makes Yucca a labeled data point rather than a ranked contender: the promo-anchored, intake-gated structure is exactly the combination our methodology records without crowning — and the "for life" lock, if it survives intake at your dose, is genuinely interesting, which is why the three questions below exist.
What the offer is, mechanically
Three mechanisms from the teaser index stack in one banner. Promo-anchoring: the rate rides a code with lifetime framing — a real structural promise if honored, and a marketing device until your enrollment confirmation states it. Term-anchoring: one forty-six is the six-month plan's arithmetic, not a monthly walk-in rate. And the load-bearing one, funnel-gating: "as low as" plus pricing-after-intake means your actual rate — at your dose, in your state — is determined inside the funnel, which is the exact structure that keeps a row unrankable in our tables regardless of how attractive the entry number is. None of this is an accusation; all of it is labeled on Yucca's own pages for a careful reader, and this page exists to be that reader. The comparison it must survive: the un-gated one thirty-nine at NexLife (promotional, with its own labeled lock), one twenty-nine at bmiMD, one thirty-three at Oak — monthly, no code, no intake reveal.
The three questions, and the verdict
At intake, in writing: What is my exact ongoing rate, at my dose, after the six-month entry plan — and does "for life" lock that number or the entry number? Which pharmacy fills my prescription in my state? — unnamed is the current public answer, and the fifteen-minute verification can't run on a blank. What are the six-month plan's billing and exit mechanics? If the answers come back as a locked one forty-six at maintenance dose, a nameable licensed pharmacy, and monthly billing with a clean exit, Yucca becomes one of the better semaglutide offers on the board — a sentence we can't yet write from public information, which is the review. Until then it ranks where our tables place it: recorded, labeled, and behind every program whose price survives contact with its own checkout. Your intake screenshots — or your filled row in our capture file — are what would move it.
Questions people ask
What does Yucca Health actually cost?
The advertised $146/mo (code YUCCA4LIFE) is a new-patient 'as low as' entry rate on a six-month semaglutide plan; tirzepatide's parallel figure is $258. Full pricing — your dose's ongoing rate — is revealed only after intake, per Yucca's own FAQ, which is why our tables record Yucca without ranking it. The un-gated alternatives: $129–$139 monthly semaglutide at bmiMD/NexLife.
Is Yucca's '$146 for life' real?
It's a real banner with real fine print: new-patient, six-month-plan, 'as low as' framing, pricing confirmed after intake. Whether 'for life' locks $146 at your maintenance dose is answerable only inside the funnel — get it in writing on your enrollment confirmation, along with the pharmacy name (currently unnamed publicly) and the plan's exit mechanics, before paying.
Why isn't Yucca ranked in your cheapest lists?
Methodology §4: intake-gated and 'as low as' entry figures aren't rankable, because the number you'd pay at maintenance isn't public. Yucca's $146/$258 entries are recorded and labeled; a confirmed post-intake maintenance rate — via checkout capture — is what would make the row rankable.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.